发明名称 Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
摘要 A method of preventing necrotizing tissue injury in the gastrointestinal tract comprising orally administering glutamine is disclosed. Glutamine protects tissues along the gastrointestinal tract by blocking translocation of bacterial agents such as gram (-) bacteria, other infectious agents, toxins, chemicals and injurious substances. The intraluminal/apical presence of the glutamine optimizes mucosal defense and increases nutrient absorption. Enteral glutamine is useful in treating neonatal necrotizing enterocolitis for reducing inflammation caused by bacterial translocation and injury. Oral glutamine is also useful in treating gastrointestinal dysfunctions. When glutamine is orally administered, it coats gastrointestinal mucosa thereby treating infectious and/or inflammatory conditions of the gastrointestinal tract. It is useful in treating pathologic conditions with lowered transepithelial electrical resistance (TEER) by acting as a curative agent.
申请公布号 US5981590(A) 申请公布日期 1999.11.09
申请号 US19970819624 申请日期 1997.03.17
申请人 PROBIOTIX, INC. 发明人 PANIGRAHI, PINAKI;HORVATH, KAROLY;GEWOLB, IRA H.
分类号 A61K31/198;(IPC1-7):A61K31/195 主分类号 A61K31/198
代理机构 代理人
主权项
地址